Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...
A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...
The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s ...
Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).
Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...
Axonics Inc. (NASDAQ:AXNX) rose 1.5% in after hours trading after a jury voted in is favor in a patent dispute with Medtronic ...
California-based medical device company Axonics has won a patent infringement trial against Medtronic, according to a Sept. 19 report from Global Data. Medtronic alleged that the company copied three ...
Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy ...
Medtronic (NYSE: MDT) today announced the publication of its novel approach to studying adaptive deep brain stimulation (aDBS ...
Medtronic is offering a peek into its ongoing, at-home trial of people with Parkinson’s disease being treated with adaptive ...
"Medtronic’s Aurora EV-ICD to challenge Boston Scientific’s S-ICD market leadership" was originally created and published by ...
The Federal Circuit revived a lawsuit against Medtronic Inc. over guide catheter technology Monday, ruling that a district ...